Citius Pharmaceuticals Inc. - נכסים נקיים למניה בודדת CTXR

Citius Pharmaceuticals (CTXR) minimizes risks through a diversified portfolio of oncology and critical care medications. The book value per common share on this GURU.Markets chart clearly demonstrates the net asset base, where the value 2.42 shows the current figure. The strategy relies on partnerships with medical centers for lymphoma therapy and the stable operation of contract manufacturing capacities.

Citius Pharmaceuticals (CTXR) investments in laboratory greening and energy efficiency directly impact the asset structure, determining the final book value per share. This indicator is calculated as the difference between all company assets and liabilities divided by the number of shares, allowing investors to assess the real value of their ownership stake in the event of liquidation.